Found 9 matching trials
A Phase II Clinical Study of SHR-1826 for Injection in Patients With NSCLC
PHASE2This study is an open-label, multicenter Phase II clinical trial to evaluat...
Location
Chinese People's Liberation Army (PLA) General Hospital
An Open Phase I Clinical Trial of SHR-1826 for Injection in Patients With Advanced Solid Tumors
PHASE1This is an open, multi-center, dose-escalation/dose-expansion/efficacy expa...
Location
Sun Yat-sen University Cancer Center
A Phase II Clinical Study of HRS-7058 in Combination With Antitumor Drugs in Patients With Advanced Malignant Tumour
PHASE2This study is a multicentre, open phase II clinical study of dose escalatio...
Location
Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
A Study of SHR-1826 Monotherapy or in Combination With Immunotherapy in the Treatment of Advanced Hepatocellular Cancer
PHASE2The study was designed to evaluate the efficacy and safety of SHR-1826 mono...
Location
Shanghai Zhongshan Hospital
A Phase Ib Study of HS-10504 Combined Therapy in NSCLC
PHASE1This is a multi-center, open-label, phase I study to evaluate the safety, e...
Location
Multiple Locations
A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With NSCLC
PHASE1This is an open label, multi-center, multiple dose Phase IB/II study to eva...
Location
Shanghai Chest Hospital
A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With Solid Tumors
PHASE1This is an open label, multi-center, multiple dose Phase IB/II study to eva...
Location
Sun Yat-Sen university cancer center
A Phase II Clinical Trial of SHR-1826 for Non-Small Cell Lung Cancer
PHASE2This study is a single-arm, open-label, multicenter phase II clinical trial...
Location
Affiliated Cancer Hospital of Shandong First Medical University
The Clinical Study of Adalimumab Combined With Other Anti-tumor Therapy as a Treatment for Resectable Non-small Cell Lung Cancer
PHASE2This study is an open-label, multicenter phase II clinical trial of adebeli...
Location
Shanghai Pulmonary Hospital